Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

797
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

531
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Time Spent With Low Posttransplant Glomerular Filtration Rate and Access to Relisting and Retransplantation.

Kidney medicine·2026
Same author

Letter Concerning Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence.

Annals of neurology·2026
Same author

Renal blood flow and progression to kidney failure in ADPKD.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Understanding the Relationship Between Severe Donor Diabetes Insipidus, Kidney Donor Profile Index, and Recipient Kidney Function.

Transplantation direct·2026
Same author

Opioid use patterns and persistent use after hemodialysis access surgery.

Journal of vascular surgery·2025
Same author

Localization of sentinel lymph nodes using augmented-reality system: a cadaveric feasibility study.

European journal of nuclear medicine and molecular imaging·2025

Related Experiment Video

Updated: Feb 26, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.5K

Contextualizing Oncologic Imaging Utilization Through End-of-Life Spending Patterns.

Timothy P Copeland1, John M Hillman2, Benjamin L Franc1

  • 1Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.

Journal of the American College of Radiology : JACR
|July 16, 2017
PubMed
Summary

Spending patterns in a patient's final year of life significantly predict high-cost imaging use in their last three months. Trajectory modeling reveals specific spending patterns are stronger predictors than proximity to death.

Keywords:
Utilization managementcancer imagingend-of-life care

More Related Videos

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

1.2K

Related Experiment Videos

Last Updated: Feb 26, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

11.5K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K
Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
07:47

Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication

Published on: December 15, 2023

1.2K

Area of Science:

  • Health Economics
  • Oncology
  • Radiology

Background:

  • Understanding factors influencing high-cost medical imaging utilization is crucial for healthcare cost management.
  • Patient spending patterns in the final year of life may offer insights into end-of-life care resource allocation.

Purpose of the Study:

  • To evaluate the association between spending patterns in the final year of life and the utilization of high-cost imaging in the final three months of life.

Main Methods:

  • A retrospective analysis of cancer patient data from an academic comprehensive cancer center.
  • Group-based trajectory modeling to identify distinct spending patterns in the final year of life.
  • Multivariate logistic regression to assess the impact of spending trajectories on high-cost imaging utilization (CT, MRI, PET) in the final three months of life.

Main Results:

  • Six distinct spending trajectories were identified.
  • Membership in the 'late rising' spending trajectory was the strongest predictor of high-cost imaging use (OR=11.61).
  • Diagnosis timing (12-6 months premortem) was also a significant predictor (OR=7.49), while spending trajectory improved predictive accuracy over temporal proximity to death.

Conclusions:

  • Patient spending trajectories and clinical severity measures are important considerations for hospital administrators estimating oncologic imaging utilization.
  • This analytical approach can inform evaluations for participation in advanced payment models and value-based care initiatives.